强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JNJ 强生

休市中 08-23 16:00:00 EDT

164.13

+1.78

+1.10%

盘后164.13

+0.000.00%

19:59 EDT

最高164.22	最低161.70	成交量709.34万
今开162.50	昨收162.35	日振幅1.56%
总市值3,951亿	流通市值3,944亿	总股本24.07亿
成交额11.58亿	换手率0.30%	流通股本24.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"强生","latestPrice":164.13,"timestamp":1724443200000,"preClose":162.35,"halted":0,"volume":7093429,"hourTrading":{"tag":"盘后","latestPrice":164.13,"preClose":164.13,"latestTime":"19:59 EDT","volume":705214,"amount":115745587.2004,"timestamp":1724457581304},"delay":0,"floatShares":2402848040,"shares":2407243667,"eps":15.450808,"marketStatus":"休市中","marketStatusCode":7,"change":1.78,"latestTime":"08-23 16:00:00 EDT","open":162.5,"high":164.22,"low":161.695,"amount":1157996254.8353498,"amplitude":0.015553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":15.450808,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":-797371200000,"adjPreClose":162.35,"adrRate":0,"dividendRate":0.029306,"preHourTrading":{"tag":"盘前","latestPrice":162.69,"preClose":162.35,"latestTime":"09:29 EDT","volume":911,"amount":147952.60391,"timestamp":1724419794744},"postHourTrading":{"tag":"盘后","latestPrice":164.13,"preClose":164.13,"latestTime":"19:59 EDT","volume":705214,"amount":115745587.2004,"timestamp":1724457581304},"volumeRatio":1.2546776930091939,"impliedVol":0.1715,"impliedVolPercentile":0.1944},"requestUrl":"/m/hq/s/JNJ/wiki","defaultTab":"wiki","newsList":[{"id":"2461502852","title":"强生突破性小分子疗法获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2461502852","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461502852?lang=zh_cn&edition=full","pubTime":"2024-08-24 12:59","pubTimestamp":1724475580,"startTime":"0","endTime":"0","summary":"格隆汇8月24日｜强生宣布，欧盟委员会已批准其小分子抑制剂Balversa（erdafitinib）作为每日一次口服单药疗法，用于治疗患有不可切除或转移性尿路上皮癌（mUC）的成人患者，这些患者具有成纤维细胞生长因子受体3（FGFR3）基因变异，并且之前接受过至少一线PD-1/PD-L1抑制剂的治疗。根据新闻稿，这是欧盟批准用于治疗带有FGFR3变异mUC成人患者的首个泛FGFR激酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082412594495ba6b08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082412594495ba6b08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE000M9KFDE8.USD","LU1066053197.SGD","LU1732799900.SGD","LU0320765646.SGD","JNJ","LU0889566641.SGD","LU1074936037.SGD","LU1059921491.USD","LU1196500208.SGD","IE0034235303.USD","LU1032466523.USD","LU0345770993.USD","LU0345770308.USD","LU1244550494.USD","LU1506573853.SGD","LU0234572021.USD","LU1221951046.USD","SG9999001440.SGD","BK4504","LU0122379950.USD","LU2347655156.SGD","LU2133065610.SGD","LU1280957306.USD","LU0640476718.USD","LU1929549753.HKD","LU0114720955.EUR","LU1244550577.SGD","LU1162221912.USD","BK4007","LU0466842654.USD","LU1914381329.SGD","LU0795875086.SGD","LU0882574055.USD","LU2602419157.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1221951129.SGD","BK4559","LU1267930813.SGD","LU1935042991.SGD","LU1066051225.USD","BK4588","LU0795875169.SGD","BK4534","BK4581","BK4533","LU1032955483.USD","BK4532"],"gpt_icon":0},{"id":"2461504574","title":"【强生突破性小分子疗法获欧盟批准】金十数据8月24日讯，强生宣布，欧盟委员会已批准其小分子抑制剂Balversa（erdafitinib）作为每日一次口服单药疗法，用于治疗患有不可切除或转移性尿路上皮癌（mUC）的成人患者，这些患者具有成纤维细胞生长因子受体3（FGFR3）基因变异，并且之前接受过至少一线PD-1/PD-L1抑制剂的治疗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2461504574","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461504574?lang=zh_cn&edition=full","pubTime":"2024-08-24 12:59","pubTimestamp":1724475547,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE0034235303.USD","LU1169589451.USD","LU1066051811.HKD","LU1585245621.USD","JNJ","IE00B1BXHZ80.USD","LU1023059063.AUD","LU1244550577.SGD","LU1162221912.USD","PD","LU0234572021.USD","LU1732799900.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD","LU1196500208.SGD","LU0912757837.SGD","BK4534","LU2133065610.SGD","LU1032466523.USD","LU2347655156.SGD","BK4588","LU1732800096.USD","LU1244550494.USD","LU1267930813.SGD","BK4504","LU1059921491.USD","BK4023","LU0640476718.USD","LU0795875086.SGD","LU1066051498.USD","BK4532","LU1280957306.USD","LU0792757196.USD","LU1261432733.SGD","IE00B19Z3581.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU1032955483.USD","LU1057294990.SGD","SG9999001440.SGD","BK4581","LU0345770308.USD","LU0345770993.USD","BK4533","LU1929549753.HKD","LU0122379950.USD","LU0320765646.SGD","BK4592"],"gpt_icon":0},{"id":"2461546240","title":"媒体-J&J 通知医院根据药物节约计划为折扣药物支付全额费用 - 华尔街日报","url":"https://stock-news.laohu8.com/highlight/detail?id=2461546240","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461546240?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:19","pubTimestamp":1724437199,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月23日 - -- 来源链接：  -- 注：路透未核实此报道，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1032466523.USD","LU0122379950.USD","LU0795875169.SGD","JNJ","IE0034235303.USD","LU1430594728.SGD","LU0792757196.USD","LU1280957306.USD","LU0882574055.USD","LU1059921491.USD","BK4504","BK4568","LU2133065610.SGD","BK4585","LU0114720955.EUR","LU1506573853.SGD","IE00B1BXHZ80.USD","LU1221951046.USD","LU1066051498.USD","BK4581","LU1066051225.USD","LU1244550221.USD","BK4592","LU1732799900.SGD","LU0889566641.SGD","LU1221951129.SGD","BK4588","LU0466842654.USD","LU1261432733.SGD","LU1162221912.USD","LU1066053197.SGD","BK4550","BK4533","LU1057294990.SGD","LU1196500208.SGD","IE0002270589.USD","LU0320765646.SGD","LU1244550494.USD","LU1074936037.SGD","LU0640476718.USD","LU1066051811.HKD","IE00B19Z3B42.SGD","LU1914381329.SGD","LU1935042991.SGD","LU2602419157.SGD","IE00B19Z3581.USD","BK4559","IE000M9KFDE8.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2461546225","title":"媒体-J&J 通知医院根据药物节约计划为折扣药物支付全额费用 - 华尔街日报","url":"https://stock-news.laohu8.com/highlight/detail?id=2461546225","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461546225?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:19","pubTimestamp":1724437199,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月23日 - -- 来源链接：  -- 注：路透未核实此报导，不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","LU1032466523.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU1914381329.SGD","LU0320765646.SGD","JNJ","BK4568","IE0034235303.USD","LU1066051225.USD","LU1074936037.SGD","LU1506573853.SGD","LU1162221912.USD","LU0795875169.SGD","LU0889566641.SGD","LU2133065610.SGD","LU1244550494.USD","IE00B19Z3B42.SGD","BK4585","BK4504","LU1732799900.SGD","LU1935042991.SGD","BK4581","BK4007","LU0122379950.USD","LU0466842654.USD","LU1066053197.SGD","BK4550","LU1221951046.USD","LU1221951129.SGD","LU1057294990.SGD","LU1066051811.HKD","IE00B1BXHZ80.USD","IE000M9KFDE8.USD","LU1066051498.USD","IE0002270589.USD","LU1280957306.USD","LU0345770993.USD","LU1059921491.USD","BK4588","LU0640476718.USD","BK4592","LU1196500208.SGD","LU1430594728.SGD","LU2602419157.SGD","BK4559","BK4533","LU1244550221.USD","LU1261432733.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2461545058","title":"J&J公司正在就65亿美元的滑石粉和解协议与持异议者进行谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2461545058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461545058?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:01","pubTimestamp":1724436067,"startTime":"0","endTime":"0","summary":"J&J公司计划，如果至少有75%的滑石粉索赔人投票支持其和解方案，就将一家子公司置于破产境地。破产和解将结束所有指控 J&J 产品导致卵巢癌的滑石粉诉讼，并将防止今后再出现类似案件。J&J 面临着来自 62,000 多名原告的诉讼，指控其婴儿爽身粉和其他滑石粉产品受到石棉污染，导致卵巢癌和其他癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU0345770308.USD","BK4532","IE0002270589.USD","LU0122379950.USD","LU0912757837.SGD","BK4533","LU1267930813.SGD","BK4559","LU0795875086.SGD","BK4550","BK4534","IE00B7SZLL34.SGD","IE00B19Z3581.USD","BK4581","LU0320765646.SGD","LU1066051498.USD","BK4504","BK4568","LU2133065610.SGD","LU1261432733.SGD","LU0795875169.SGD","LU1732800096.USD","LU1430594728.SGD","LU1066051811.HKD","LU1244550577.SGD","LU1032955483.USD","LU1914381329.SGD","LU1057294990.SGD","LU1074936037.SGD","LU1280957306.USD","IE000M9KFDE8.USD","LU0792757196.USD","LU1162221912.USD","BK4007","LU2468319806.SGD","IE0034235303.USD","LU1066051225.USD","SG9999001440.SGD","LU0882574055.USD","LU1732799900.SGD","IE00BSNM7G36.USD","LU0345770993.USD","IE00B1BXHZ80.USD","LU1023059063.AUD","LU2347655156.SGD","LU1929549753.HKD","IE00B19Z3B42.SGD","JNJ","LU1585245621.USD"],"gpt_icon":0},{"id":"2461539601","title":"医药行业周报：强生双抗RYBREVANT联合疗法获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2461539601","media":"太平洋证券股份...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461539601?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:00","pubTimestamp":1724342400,"startTime":"0","endTime":"0","summary":"行业要闻：8 月21 日，强生宣布，美国FDA 批准其双特异性抗体Rybrevant联合Lazcluze用于一线治疗经美国FDA批准检测证实带有EGFR 外显子19 缺失或外显子21 中L858R 替代突变的局部晚期或转移性非小细胞肺癌成年患者。此前临床试验结果显示，与活性对照药物相比，Rybrevant 与Lazcluze 联合疗法可降低患者疾病进展或死亡风险达30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082314060795b6d146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082314060795b6d146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","IE000M9KFDE8.USD","LU0792757196.USD","LU1066053197.SGD","LU1244550221.USD","LU1732799900.SGD","JNJ","LU1074936037.SGD","IE00B1BXHZ80.USD","LU1059921491.USD","LU1261432733.SGD","LU1196500208.SGD","IE0034235303.USD","LU1023059063.AUD","LU1066051498.USD","LU1032466523.USD","IE00B7SZLL34.SGD","LU0345770993.USD","LU0345770308.USD","SG9999001440.SGD","LU0234572021.USD","LU1066051811.HKD","LU1430594728.SGD","BK4504","LU0122379950.USD","LU2347655156.SGD","LU2133065610.SGD","LU0640476718.USD","LU2468319806.SGD","IE00BSNM7G36.USD","LU1929549753.HKD","LU0114720955.EUR","LU1244550577.SGD","BK4007","LU0882574055.USD","IE00B19Z3581.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU1267930813.SGD","LU1585245621.USD","LU1057294990.SGD","LU1732800096.USD","LU1066051225.USD","BK4588","LU0795875169.SGD","BK4534","BK4581","BK4585","LU1032955483.USD","LU0889566641.SGD"],"gpt_icon":0},{"id":"2461236847","title":"斥资17亿美元！强生四个月内再收购一家心血管医疗器械公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2461236847","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461236847?lang=zh_cn&edition=full","pubTime":"2024-08-21 19:52","pubTimestamp":1724241133,"startTime":"0","endTime":"0","summary":"当地时间8月20日，强生公司宣布以最高17亿美元价格收购以色列心力衰竭植入医疗器械公司V-Wave。这是继今年4月强生以约130亿美元的价格收购Shockwave公司之后的又一笔心血管领域的布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202408213161776793.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202408213161776793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1221951129.SGD","09996","BK4592","LU0345770993.USD","LU1059921491.USD","JNJ","LU0466842654.USD","LU1032955483.USD","LU1221951046.USD","BK4588","BK4533","LU1162221912.USD","BK4568","BK4581","LU1066053197.SGD","LU1506573853.SGD","LU1732800096.USD","LU1196500208.SGD","LU0345770308.USD","IE00B19Z3581.USD","LU0912757837.SGD","LU1244550577.SGD","LU0795875169.SGD","LU0795875086.SGD","LU2602419157.SGD","LU0234572021.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1244550221.USD","BK4532","SG9999001440.SGD","BK4504","BK4007","LU0640476718.USD","LU2347655156.SGD","LU1935042991.SGD","LU1430594728.SGD","BK4585","LU2133065610.SGD","BK1574","LU1585245621.USD","LU1929549753.HKD","LU0114720955.EUR","09997","LU1074936037.SGD","LU1244550494.USD","LU1267930813.SGD","LU1032466523.USD","LU0889566641.SGD","BK1100"],"gpt_icon":0},{"id":"2461819790","title":"121亿收购！强生又一大动作！","url":"https://stock-news.laohu8.com/highlight/detail?id=2461819790","media":"思宇MedTech","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461819790?lang=zh_cn&edition=full","pubTime":"2024-08-21 15:58","pubTimestamp":1724227093,"startTime":"0","endTime":"0","summary":"第二届全球手术机器人大会腔镜手术机器人产品课｜医美大赛报名启动2024年8月20日，强生集团宣布达成收购心房分流器制造商 V-Wave 的最终协议。监管信息目前，并未有任何一款心房分流器产品得到 FDA 的批准，但强生相信 V-Wave 的心房分流器Ventura 有望成为 FDA 批准的第一款心房分流器。术后30天没有发生重大心血管或神经系统不良事件，24个月也没有发生类似不良事件。Laminar 将并入强生旗下专门负责心脏电生理业务的子公司 Biosense Webster。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082116254095add979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082116254095add979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IE00B7SZLL34.SGD","LU0889566641.SGD","LU1221951129.SGD","LU1585245621.USD","LU0234572021.USD","BK4588","LU0114720955.EUR","LU0345770993.USD","LU0795875086.SGD","LU1059921491.USD","LU1267930813.SGD","LU2347655156.SGD","LU1929549753.HKD","BK4504","LU0792757196.USD","LU1032955483.USD","LU1430594728.SGD","BK4581","LU1244550494.USD","IE0002270589.USD","LU1066053197.SGD","LU1935042991.SGD","LU1057294990.SGD","LU0640476718.USD","LU1162221912.USD","LU1244550577.SGD","LU0912757837.SGD","SG9999001440.SGD","BK4592","LU0466842654.USD","LU2602419157.SGD","LU2468319806.SGD","JNJ","LU1032466523.USD","IE00BSNM7G36.USD","LU0345770308.USD","IE00B19Z3581.USD","LU1261432733.SGD","LU2133065610.SGD","LU1732800096.USD","BK4532","LU1244550221.USD","LU1023059063.AUD","BK4585","LU1074936037.SGD","LU1506573853.SGD","LU1221951046.USD","LU1196500208.SGD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2461567118","title":"隔夜美股全复盘(8.21)| 京东盘后一度跌大跌11%，沃尔玛拟出售京东价值37.4亿美元的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2461567118","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461567118?lang=zh_cn&edition=full","pubTime":"2024-08-21 07:14","pubTimestamp":1724195640,"startTime":"0","endTime":"0","summary":"京东盘后一度大跌11%，沃尔玛拟出售京东价值37.4亿美元的股份","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/940020","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0306807586.USD","BK1142","LU0882574139.USD","09618","LU0488056044.USD","LU0594300419.USD","NVDA","GPRO","LU0359201612.USD","TSLA","BMY","AAPL","AMZN","IE0004091025.USD","SG9999002463.SGD","LU1670711040.USD","LU0084288322.USD","BILI","IE0008368742.USD","IE00BJJMRY28.SGD","BABA","LU0234570918.USD","LU0256863902.USD","EVS.SI","MSFT","LU0471298777.SGD","IE00BSNM7G36.USD","LU0140636845.USD","LU0370786039.SGD","PDD","LU0053666078.USD","LU0289739699.SGD","IE00B1BXHZ80.USD","JNJ","IE00BN8TJ469.HKD","LU0823414478.USD","LU0306806265.USD","LU1032466523.USD","LU0048580855.USD","NIO","LLY","LU0234572021.USD","IE00BK4W5L77.USD","IE00B3SWFQ91.USD","89618","IE00BK4W5M84.HKD","LU1720051108.HKD","META","XPEV","LKNCY","LU2326559502.SGD","GOOG","JD","WMT","IE0005OL40V9.USD","LU0345770993.USD","LU0082616367.USD","LU2250418816.HKD","LU0106261372.USD"],"gpt_icon":1},{"id":"2460885125","title":"更新版 2-更正-J&J 拟以最高 17 亿美元收购医疗设备制造商 V-Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=2460885125","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460885125?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:36","pubTimestamp":1724168177,"startTime":"0","endTime":"0","summary":"J&J 表示，它将支付 6 亿美元的预付款，并将根据监管和商业里程碑情况支付高达 11 亿美元的潜在款项。该交易是 J&J 一系列收购中的最新一笔，因为 J&J 希望在 2025 年之后推动增长，届时银屑病大片药物 Stelara 预计将面临生物仿制药的竞争。今年 4 月，J&J 表示将收购 Shockwave Medical   ，包括债务在内的交易价值为 131 亿美元。V-Wave 的设备通过微创手术植入心脏，有助于减少心力衰竭和其他心血管事件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU1221951129.SGD","LU1066051811.HKD","IE0002270589.USD","JNJ","LU0466842654.USD","LU1732799900.SGD","BK4559","IE0034235303.USD","LU1221951046.USD","IE000M9KFDE8.USD","BK4533","BK4568","LU1066053197.SGD","LU1506573853.SGD","LU1732800096.USD","LU0345770308.USD","LU0122379950.USD","LU0320765646.SGD","LU0912757837.SGD","LU1057294990.SGD","LU0795875169.SGD","LU1244550577.SGD","LU2602419157.SGD","LU0234572021.USD","LU2468319806.SGD","LU1244550221.USD","LU1023059063.AUD","BK4532","SG9999001440.SGD","BK4007","LU2347655156.SGD","LU1066051498.USD","LU1261432733.SGD","LU1935042991.SGD","BK4550","LU1066051225.USD","BK4585","LU0882574055.USD","IE00B1BXHZ80.USD","LU1585245621.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1074936037.SGD","BK4534","LU0792757196.USD","LU1267930813.SGD","LU1914381329.SGD","LU0889566641.SGD","LU1280957306.USD"],"gpt_icon":0},{"id":"1116306660","title":"强生同意收购医疗设备公司V-Wave，总价约11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116306660","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116306660?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:48","pubTimestamp":1724165335,"startTime":"0","endTime":"0","summary":"V-Wave专注于心血管疾病治疗方案。","market":"us","thumbnail":"https://static.tigerbbs.com/48f0223e2d5a4951b40bbe06eb775655","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/48f0223e2d5a4951b40bbe06eb775655"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1167276.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JNJ"],"gpt_icon":0},{"id":"2460003688","title":"BUZZ--美国股票走势-Torrid Holdings、Treasure Global、Titan Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2460003688","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460003688?lang=zh_cn&edition=full","pubTime":"2024-08-20 20:27","pubTimestamp":1724156869,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月20日 - 美国股指期货周二走势平淡，因为在美联储最新会议纪要公布以及美联储主席鲍威尔本周晚些时候在杰克森霍尔发表讲话之前，市场对美联储9月份降息的押注趋于坚定。美东时间7:33，道指电子盘  下跌0.03%，报41,007点。标普500指数小型股  上涨0.05%，报5,632.75点；纳斯达克100指数小型股  上涨0.05%，报19,866.75点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XPEV","BK1539","DBGI","IE00B1BXHZ80.USD","LU1244550494.USD","LU2602419157.SGD","LU1974910355.USD","BK4504","FN","BK1119","LU0640476718.USD","IE00B19Z8X17.USD","HA","IE00B19Z3B42.SGD","LU1720051108.HKD","PDD","LU1929549753.HKD","LU0114720955.EUR","BK4505","AUUD","LU1162221912.USD","IE0002270589.USD","BA","DHX","BK4187","LU0466842654.USD","IE00BMPRXR70.SGD","LU1267930813.SGD","BK4500","LU1585245621.USD","09868","BK4509","IE00BSNM7G36.USD","BK4503","LU1430594728.SGD","PRPL","LOW","LU1280957306.USD","LU0889566641.SGD","LU1506573853.SGD","KYMR","PANW","JNJ","LU0348723411.USD","LU0640798160.USD","VLD","LU2468319806.SGD","LU1935042991.SGD","LU1066051498.USD","LU1244550577.SGD","LU1548497426.USD","VIPS"],"gpt_icon":1},{"id":"2460070908","title":"更新版 1-J&J 拟以最高 11 亿美元收购医疗器械制造商 V-Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=2460070908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460070908?lang=zh_cn&edition=full","pubTime":"2024-08-20 19:58","pubTimestamp":1724155091,"startTime":"0","endTime":"0","summary":"     路透8月20日 - 强生公司  周二表示，将以不超过 11 亿美元的价格收购医疗设备制造商 V-Wave，这是 该公司一系列收购中的最新一笔，目的是在 其大片药物 Stelara 失去专利保护后推动 增长。强生公司表示，它将支付 6 亿美元的预付款，并将根据监管和商业里程碑情况支付高达 11 亿美元的潜在款项。V-Wave 的设备通过微创手术植入心脏，有助于减少心力衰竭和其他事件的发生。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2460077685","title":"J&J 将以高达 11 亿美元的交易收购医疗设备制造商 V-Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=2460077685","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460077685?lang=zh_cn&edition=full","pubTime":"2024-08-20 19:37","pubTimestamp":1724153820,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月20日 - 强生公司  周二表示，它将收购医疗设备制造商V-Wave，交易价值可能高达11亿美元，这是强生公司为加强其设备部门而进行的最新一次收购。 J&J 表示将支付 6 亿美元的预付款，其余款项将视监管和商业里程碑而定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU1506573853.SGD","LU0345770993.USD","LU1066053197.SGD","LU1430594728.SGD","LU1066051811.HKD","LU1280957306.USD","LU1066051498.USD","LU0795875169.SGD","LU0889566641.SGD","LU0792757196.USD","LU1244550221.USD","LU0640476718.USD","LU0466842654.USD","LU1244550494.USD","BK4592","LU1032466523.USD","BK4533","LU2468319806.SGD","IE0002270589.USD","BK4007","BK4532","LU1914381329.SGD","BK4550","LU2602419157.SGD","BK4559","LU1732800096.USD","LU1196500208.SGD","LU0882574055.USD","IE0034235303.USD","LU1935042991.SGD","LU1074936037.SGD","LU0320765646.SGD","IE000M9KFDE8.USD","BK4534","LU1732799900.SGD","BK4585","LU0122379950.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","JNJ","LU1066051225.USD","BK4588","LU1221951046.USD","LU1221951129.SGD","LU1059921491.USD","BK4568","LU0114720955.EUR"],"gpt_icon":0},{"id":"2460074934","title":"美国 FDA 批准 J&J 公司针对肺癌类型的联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2460074934","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460074934?lang=zh_cn&edition=full","pubTime":"2024-08-20 19:09","pubTimestamp":1724152167,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透8月20日 - 美国食品和药物管理局周二批准了强生公司  为一种非小细胞肺癌患者提供的无化疗联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2460101611","title":"风和医疗IPO：研发捉急还有专利纠纷 对赌协议未清理完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2460101611","media":"电鳗快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460101611?lang=zh_cn&edition=full","pubTime":"2024-08-20 09:38","pubTimestamp":1724117880,"startTime":"0","endTime":"0","summary":"《电鳗财经》文/尹秋彤        6月29日，江苏风和医疗器材股份有限公司(以下简称“风和医疗”)在沪市科创板已更新提交相关财务资料，保荐机构为中国国际金融股份有限公司。招股书显示，风和医疗拟融资金额8亿元，用于微创高端医疗耗材及机器人项目的生产制造，包括生产制造和研发项目 2个子项目，建设周期均为 3年...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OrlUFGqr9a397p1P1hcGkqrggUXbuaLbHPyQCxNOO10MMAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OrlUFGqr9a397p1P1hcGkqrggUXbuaLbHPyQCxNOO10MMAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240820A01Q9S00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240820A01Q9S00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BSNM7G36.USD","LU0795875169.SGD","LU0114720955.EUR","LU1430594728.SGD","LU2133065610.SGD","LU2468319806.SGD","BK4559","JNJ","IE00B19Z3581.USD","LU1585245621.USD","BK4581","LU0795875086.SGD","LU1929549753.HKD","LU1935042991.SGD","LU0345770308.USD","BK4532","BK4588","LU1057294990.SGD","SG9999001440.SGD","LU1506573853.SGD","IE00B7SZLL34.SGD","LU1023059063.AUD","LU0466842654.USD","BK4568","LU0640476718.USD","LU0889566641.SGD","LU1032955483.USD","BK4550","LU1244550221.USD","LU1074936037.SGD","LU1066053197.SGD","LU2602419157.SGD","LU1032466523.USD","LU1162221912.USD","LU0234572021.USD","LU1267930813.SGD","LU1244550577.SGD","LU2347655156.SGD","LU0912757837.SGD","LU1221951129.SGD","LU0345770993.USD","LU1059921491.USD","LU1221951046.USD","BK4592","LU1196500208.SGD","LU0792757196.USD","BK4585","BK4504","LU1244550494.USD","LU1732800096.USD"],"gpt_icon":0},{"id":"2460753367","title":"标普最新制药业评级揭晓：强生(JNJ.US)与罗氏(RHHBY.US)以卓越财务与创新能力位居榜首","url":"https://stock-news.laohu8.com/highlight/detail?id=2460753367","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460753367?lang=zh_cn&edition=full","pubTime":"2024-08-19 11:30","pubTimestamp":1724038239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在标普全球制药业实力评级中，强生公司和罗氏以其卓越的表现位居榜首，该评级涵盖了全球前17家顶级制药商的综合评估。诺和诺德和礼来公司则因糖尿病和肥胖症产品的热销而股价飙升，它们在业务风险上排在“强”类别，财务风险上诺和诺德更是被评为“最小”。标普认为，规模经济、谈判能力和市场领导地位是规模较大公司的主要竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1166039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RHHBY","JNJ"],"gpt_icon":1},{"id":"2459721821","title":"拉扯15年，强生想用460亿元了结所有卵巢癌纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=2459721821","media":"三亿世代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459721821?lang=zh_cn&edition=full","pubTime":"2024-08-16 19:19","pubTimestamp":1723807151,"startTime":"0","endTime":"0","summary":"历时15年，强生爽身粉致癌案即将落下帷幕。在和解方案中，强生承诺将在25年内向卵巢癌索赔者支付约64.75亿美元的赔偿，以解决目前及未来涉及其和关联公司因爽身粉诉讼中和卵巢癌相关索赔。2023年全年，强生公司净利润为351.53亿美元。2021年10月，强生通过“分拆合并”成立了LTL Management，承接所有和爽身粉相关的法律责任。随后，LTL在北卡罗来纳州申请了第11章破产，但案件随后被转移至强生公司所在地新泽西州。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816194407959eae91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816194407959eae91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","LU0795875169.SGD","LU1066051811.HKD","LU0114720955.EUR","LU1430594728.SGD","IE0034235303.USD","LU1914381329.SGD","LU1066051498.USD","JNJ","IE00B19Z3581.USD","LU0320765646.SGD","LU1585245621.USD","BK4581","LU0795875086.SGD","LU1935042991.SGD","BK4534","LU0882574055.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","BK4588","SG9999001440.SGD","LU1066051225.USD","LU1506573853.SGD","LU1280957306.USD","IE00B7SZLL34.SGD","LU0466842654.USD","BK4568","LU0640476718.USD","LU0889566641.SGD","BK4550","LU1244550221.USD","LU1074936037.SGD","LU1066053197.SGD","LU2602419157.SGD","LU1032466523.USD","LU1162221912.USD","LU0234572021.USD","LU1267930813.SGD","IE00B1BXHZ80.USD","LU1244550577.SGD","LU0912757837.SGD","LU1221951129.SGD","LU1059921491.USD","LU1221951046.USD","BK4592","LU1196500208.SGD","LU1732800096.USD","BK4585","LU1244550494.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2459402229","title":"更新版 1-更新 1-药物研发受挫，Lykos 将裁员 75%，创始人退出董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2459402229","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459402229?lang=zh_cn&edition=full","pubTime":"2024-08-16 04:05","pubTimestamp":1723752325,"startTime":"0","endTime":"0","summary":"     路透8月15日 - Lykos Therapeutics公司  将裁员  75% ，其创始人 Rick Doblin将 离开 董事会，该公司在美国 FDA 拒绝批准其基于亚甲二氧基甲基苯丙胺的创伤后应激障碍治疗几天后于周四表示。该公司表示，计划要求美国食品及药物管理局 重新考虑其决定，并将尝试 重新提交申请，寻求批准摇头丸胶囊。Lykos表示计划 裁员75%，但没有提供受影响岗位的 数量、性质或地点等 详细信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0},{"id":"2459978409","title":"更新 1-基于摇头丸的创伤后应激障碍药物在 FDA 遭到挫折后，Lykos 将裁员 75","url":"https://stock-news.laohu8.com/highlight/detail?id=2459978409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459978409?lang=zh_cn&edition=full","pubTime":"2024-08-16 02:43","pubTimestamp":1723747426,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (全文增加细节)    路透8月15日 - LykosTherapeutics 公司周四表示，该公司将裁员 75%，并启动一些高管变动，几天前美国食品药品管理局拒绝批准该公司基于亚甲二氧基甲基苯丙胺的创伤后应激障碍治疗方法。Lykos公司的前身是MAPS公共福利公司，该公司表示其创始人里克-多布林（Rick Doblin）将离开公司董事会。     Lykos公司表示将邀请强生公司（Johnson & Johnson   ）前研发副总裁大卫-霍夫（David Hough）来领导和监督Lykos公司的临床开发项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jnj.com","stockEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0502},{"period":"3month","weight":0.1168},{"period":"6month","weight":0.0141},{"period":"1year","weight":-0.0058},{"period":"ytd","weight":0.0471}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"强生公司于1887年在新泽西州成立。强生公司及其子公司在全球拥有大约152,700名员工，从事医疗保健领域的广泛产品的研发，生产和销售。强生公司是一家控股公司，在全球几乎所有国家/地区都有260多家运营公司开展业务。公司的主要重点是与人类健康和福祉相关的产品。强生执行委员会是主要的管理团队，负责公司的战略运营和资源分配。委员会负责监督和协调公司三个业务部门的活动：消费者，制药和医疗设备。","yearOnYearQuotes":[{"month":1,"riseRate":0.522727,"avgChangeRate":0.000425},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005666},{"month":3,"riseRate":0.590909,"avgChangeRate":0.016904},{"month":4,"riseRate":0.644444,"avgChangeRate":0.034378},{"month":5,"riseRate":0.488889,"avgChangeRate":-0.026323},{"month":6,"riseRate":0.511111,"avgChangeRate":0.006092},{"month":7,"riseRate":0.6,"avgChangeRate":0.012531},{"month":8,"riseRate":0.511111,"avgChangeRate":0.00334},{"month":9,"riseRate":0.5,"avgChangeRate":0.003139},{"month":10,"riseRate":0.704545,"avgChangeRate":0.022035},{"month":11,"riseRate":0.613636,"avgChangeRate":0.017008},{"month":12,"riseRate":0.659091,"avgChangeRate":0.014337}],"exchange":"NYSE","name":"强生","nameEN":"Johnson & Johnson"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"强生,JNJ,强生股票,强生股票老虎,强生股票老虎国际,强生行情,强生股票行情,强生股价,强生股市,强生股票价格,强生股票交易,强生股票购买,强生股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"强生(JNJ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供强生(JNJ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}